AU2023252915A1 - Use of irak4 modulators for gene therapy - Google Patents

Info

Publication number

AU2023252915A1

AU2023252915A1 AU2023252915A AU2023252915A AU2023252915A1 AU 2023252915 A1 AU2023252915 A1 AU 2023252915A1 AU 2023252915 A AU2023252915 A AU 2023252915A AU 2023252915 A AU2023252915 A AU 2023252915A AU 2023252915 A1 AU2023252915 A1 AU 2023252915A1

Authority

AU

Australia

Prior art keywords

irak

gene therapy

capsid

aav

modulator

Prior art date

2022-04-12

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 238000001415 gene therapy Methods 0.000 title claims abstract description 428
• 239000003795 chemical substances by application Substances 0.000 claims abstract description 346
• 238000000034 method Methods 0.000 claims abstract description 311
• 241000700584 Simplexvirus Species 0.000 claims abstract description 104
• 241000701161 unidentified adenovirus Species 0.000 claims abstract description 82
• 150000002632 lipids Chemical class 0.000 claims abstract description 78
• 229940126005 IRAK4 degrader Drugs 0.000 claims abstract description 72
• 239000002105 nanoparticle Substances 0.000 claims abstract description 60
• 241000713666 Lentivirus Species 0.000 claims abstract description 58
• 241000702421 Dependoparvovirus Species 0.000 claims abstract description 44
• 238000011282 treatment Methods 0.000 claims abstract description 43
• 230000015788 innate immune response Effects 0.000 claims abstract description 25
• 239000002245 particle Substances 0.000 claims description 357
• 102100036342 Interleukin-1 receptor-associated kinase 1 Human genes 0.000 claims description 308
• 101710199015 Interleukin-1 receptor-associated kinase 1 Proteins 0.000 claims description 308
• 210000000234 capsid Anatomy 0.000 claims description 239
• 210000004027 cell Anatomy 0.000 claims description 170
• 102000004127 Cytokines Human genes 0.000 claims description 127
• 108090000695 Cytokines Proteins 0.000 claims description 127
• 150000007523 nucleic acids Chemical class 0.000 claims description 126
• 230000014509 gene expression Effects 0.000 claims description 121
• 239000000203 mixture Substances 0.000 claims description 113
• 210000002865 immune cell Anatomy 0.000 claims description 99
• 102000039446 nucleic acids Human genes 0.000 claims description 96
• 108020004707 nucleic acids Proteins 0.000 claims description 96
• 210000004443 dendritic cell Anatomy 0.000 claims description 86
• IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 75
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 73
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 70
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 70
• 125000005842 heteroatom Chemical group 0.000 claims description 70
• 229910052757 nitrogen Inorganic materials 0.000 claims description 70
• 229910052760 oxygen Inorganic materials 0.000 claims description 70
• 239000001301 oxygen Chemical group 0.000 claims description 70
• 229910052717 sulfur Chemical group 0.000 claims description 70
• 239000011593 sulfur Chemical group 0.000 claims description 70
• 235000001508 sulfur Nutrition 0.000 claims description 70
• 229960005349 sulfur Drugs 0.000 claims description 70
• 210000001616 monocyte Anatomy 0.000 claims description 68
• 230000003612 virological effect Effects 0.000 claims description 68
• QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 65
• 238000004519 manufacturing process Methods 0.000 claims description 61
• 239000013603 viral vector Substances 0.000 claims description 56
• 229910052739 hydrogen Inorganic materials 0.000 claims description 50
• 239000001257 hydrogen Substances 0.000 claims description 50
• 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 50
• 241000702423 Adeno-associated virus - 2 Species 0.000 claims description 45
• 230000028993 immune response Effects 0.000 claims description 42
• 230000001965 increasing effect Effects 0.000 claims description 42
• 150000001875 compounds Chemical class 0.000 claims description 39
• 108700019146 Transgenes Proteins 0.000 claims description 38
• 241000700605 Viruses Species 0.000 claims description 36
• 125000004093 cyano group Chemical group *C#N 0.000 claims description 35
• 208000035475 disorder Diseases 0.000 claims description 35
• 229910052736 halogen Inorganic materials 0.000 claims description 35
• 150000002367 halogens Chemical class 0.000 claims description 35
• 125000000623 heterocyclic group Chemical group 0.000 claims description 35
• 229920006395 saturated elastomer Polymers 0.000 claims description 35
• 102100023533 Interleukin-1 receptor-associated kinase 4 Human genes 0.000 claims description 33
• 108090001005 Interleukin-6 Proteins 0.000 claims description 33
• 102000004889 Interleukin-6 Human genes 0.000 claims description 33
• 201000010099 disease Diseases 0.000 claims description 32
• 125000001931 aliphatic group Chemical group 0.000 claims description 30
• -1 R6a Chemical class 0.000 claims description 28
• 239000003814 drug Substances 0.000 claims description 28
• 230000000694 effects Effects 0.000 claims description 28
• 102100021943 C-C motif chemokine 2 Human genes 0.000 claims description 26
• 101710091439 Major capsid protein 1 Proteins 0.000 claims description 26
• 238000011534 incubation Methods 0.000 claims description 26
• 125000002619 bicyclic group Chemical group 0.000 claims description 25
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 25
• 239000001064 degrader Substances 0.000 claims description 24
• 230000035772 mutation Effects 0.000 claims description 24
• 150000003839 salts Chemical class 0.000 claims description 22
• 241001655883 Adeno-associated virus - 1 Species 0.000 claims description 20
• 125000002950 monocyclic group Chemical group 0.000 claims description 20
• JKDGKIBAOAFRPJ-ZBINZKHDSA-N C(C)[C@H]1[C@H](NC([C@H]1F)=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N Chemical compound C(C)[C@H]1[C@H](NC([C@H]1F)=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N JKDGKIBAOAFRPJ-ZBINZKHDSA-N 0.000 claims description 19
• 230000001939 inductive effect Effects 0.000 claims description 17
• 241000712899 Lymphocytic choriomeningitis mammarenavirus Species 0.000 claims description 16
• 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims description 15
• 108010060818 Toll-Like Receptor 9 Proteins 0.000 claims description 15
• 102100033117 Toll-like receptor 9 Human genes 0.000 claims description 15
• 125000004429 atom Chemical group 0.000 claims description 15
• 125000002837 carbocyclic group Chemical group 0.000 claims description 15
• 241001634120 Adeno-associated virus - 5 Species 0.000 claims description 14
• 241000972680 Adeno-associated virus - 6 Species 0.000 claims description 14
• 241000283690 Bos taurus Species 0.000 claims description 14
• 239000006143 cell culture medium Substances 0.000 claims description 14
• 241000202702 Adeno-associated virus - 3 Species 0.000 claims description 13
• 241000580270 Adeno-associated virus - 4 Species 0.000 claims description 13
• 241001164823 Adeno-associated virus - 7 Species 0.000 claims description 13
• 241001164825 Adeno-associated virus - 8 Species 0.000 claims description 13
• 241000649045 Adeno-associated virus 10 Species 0.000 claims description 13
• 241000649046 Adeno-associated virus 11 Species 0.000 claims description 13
• 241000649047 Adeno-associated virus 12 Species 0.000 claims description 13
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 13
• 101710199010 Interleukin-1 receptor-associated kinase 4 Proteins 0.000 claims description 12
• 208000024556 Mendelian disease Diseases 0.000 claims description 12
• 241000711975 Vesicular stomatitis virus Species 0.000 claims description 12
• 239000003112 inhibitor Substances 0.000 claims description 12
• 210000002540 macrophage Anatomy 0.000 claims description 12
• 108091070501 miRNA Proteins 0.000 claims description 12
• 239000002679 microRNA Substances 0.000 claims description 12
• 108090000994 Catalytic RNA Proteins 0.000 claims description 11
• 102000053642 Catalytic RNA Human genes 0.000 claims description 11
• 108091027967 Small hairpin RNA Proteins 0.000 claims description 11
• 230000009368 gene silencing by RNA Effects 0.000 claims description 11
• 108091092562 ribozyme Proteins 0.000 claims description 11
• 239000004055 small Interfering RNA Substances 0.000 claims description 11
• 108091030071 RNAI Proteins 0.000 claims description 10
• 125000002527 bicyclic carbocyclic group Chemical group 0.000 claims description 10
• 108020005544 Antisense RNA Proteins 0.000 claims description 9
• 108091027757 Deoxyribozyme Proteins 0.000 claims description 9
• 102100023530 Interleukin-1 receptor-associated kinase 3 Human genes 0.000 claims description 9
• 101710199012 Interleukin-1 receptor-associated kinase 3 Proteins 0.000 claims description 9
• 239000003184 complementary RNA Substances 0.000 claims description 9
• 108091033409 CRISPR Proteins 0.000 claims description 8
• 238000010354 CRISPR gene editing Methods 0.000 claims description 8
• 241000283707 Capra Species 0.000 claims description 8
• 241000700588 Human alphaherpesvirus 1 Species 0.000 claims description 8
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 8
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 8
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 7
• 241000701074 Human alphaherpesvirus 2 Species 0.000 claims description 7
• 229920000669 heparin Polymers 0.000 claims description 7
• 229960002897 heparin Drugs 0.000 claims description 7
• 241000282465 Canis Species 0.000 claims description 6
• 241001115402 Ebolavirus Species 0.000 claims description 6
• 206010066919 Epidemic polyarthritis Diseases 0.000 claims description 6
• 241000046923 Human bocavirus Species 0.000 claims description 6
• 101710182491 Interleukin-1 receptor-associated kinase-like 2 Proteins 0.000 claims description 6
• 102100036433 Interleukin-1 receptor-associated kinase-like 2 Human genes 0.000 claims description 6
• 241001115401 Marburgvirus Species 0.000 claims description 6
• 241000711798 Rabies lyssavirus Species 0.000 claims description 6
• 241000710942 Ross River virus Species 0.000 claims description 6
• 238000007792 addition Methods 0.000 claims description 6
• 239000013646 rAAV2 vector Substances 0.000 claims description 6
• 125000006163 5-membered heteroaryl group Chemical group 0.000 claims description 5
• 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 claims description 5
• 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 claims description 5
• 125000003118 aryl group Chemical group 0.000 claims description 5
• 125000004452 carbocyclyl group Chemical group 0.000 claims description 5
• 125000001072 heteroaryl group Chemical group 0.000 claims description 5
• 125000001183 hydrocarbyl group Chemical group 0.000 claims description 5
• 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims description 5
• 125000004433 nitrogen atom Chemical group N* 0.000 claims description 5
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims description 5
• 229930195734 saturated hydrocarbon Natural products 0.000 claims description 5
• 150000003384 small molecules Chemical group 0.000 claims description 5
• 229930195735 unsaturated hydrocarbon Natural products 0.000 claims description 5
• 108020004459 Small interfering RNA Proteins 0.000 claims 2
• 238000011865 proteolysis targeting chimera technique Methods 0.000 claims 2
• 229940124823 proteolysis targeting chimeric molecule Drugs 0.000 claims 2
• 108010026668 snake venom protein C activator Proteins 0.000 claims 2
• 125000003473 lipid group Chemical group 0.000 claims 1
• 239000013598 vector Substances 0.000 abstract description 91
• 230000002708 enhancing effect Effects 0.000 abstract description 2
• 108090000623 proteins and genes Proteins 0.000 description 82
• 230000001225 therapeutic effect Effects 0.000 description 52
• 108090000765 processed proteins & peptides Proteins 0.000 description 39
• 230000006870 function Effects 0.000 description 36
• 102000004196 processed proteins & peptides Human genes 0.000 description 36
• 229920001184 polypeptide Polymers 0.000 description 35
• 108091028043 Nucleic acid sequence Proteins 0.000 description 28
• 102000004169 proteins and genes Human genes 0.000 description 28
• 210000001519 tissue Anatomy 0.000 description 27
• 239000013612 plasmid Substances 0.000 description 25
• 235000018102 proteins Nutrition 0.000 description 25
• 108090000565 Capsid Proteins Proteins 0.000 description 24
• 102100023321 Ceruloplasmin Human genes 0.000 description 24
• 101000977771 Homo sapiens Interleukin-1 receptor-associated kinase 4 Proteins 0.000 description 21
• 108020004414 DNA Proteins 0.000 description 17
• 238000004806 packaging method and process Methods 0.000 description 16
• 208000015181 infectious disease Diseases 0.000 description 15
• 238000001890 transfection Methods 0.000 description 15
• 208000002267 Anti-neutrophil cytoplasmic antibody-associated vasculitis Diseases 0.000 description 14
• 108091033319 polynucleotide Proteins 0.000 description 14
• 102000040430 polynucleotide Human genes 0.000 description 14
• 239000002157 polynucleotide Substances 0.000 description 14
• 229940127590 IRAK4 inhibitor Drugs 0.000 description 13
• 230000002458 infectious effect Effects 0.000 description 13
• 239000008194 pharmaceutical composition Substances 0.000 description 13
• 239000000546 pharmaceutical excipient Substances 0.000 description 13
• 238000010361 transduction Methods 0.000 description 13
• 230000026683 transduction Effects 0.000 description 13
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
• 150000001413 amino acids Chemical class 0.000 description 12
• 230000001976 improved effect Effects 0.000 description 12
• 239000002773 nucleotide Substances 0.000 description 12
• 230000009467 reduction Effects 0.000 description 12
• 230000010076 replication Effects 0.000 description 12
• 239000013607 AAV vector Substances 0.000 description 11
• 208000015439 Lysosomal storage disease Diseases 0.000 description 11
• 241000699666 Mus <mouse, genus> Species 0.000 description 11
• 102000002689 Toll-like receptor Human genes 0.000 description 11
• 108020000411 Toll-like receptor Proteins 0.000 description 11
• 125000003729 nucleotide group Chemical group 0.000 description 11
• 239000000243 solution Substances 0.000 description 11
• 239000000126 substance Substances 0.000 description 11
• 239000000725 suspension Substances 0.000 description 10
• 229940125359 zimlovisertib Drugs 0.000 description 10
• 241000701022 Cytomegalovirus Species 0.000 description 9
• 239000013608 rAAV vector Substances 0.000 description 9
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 8
• 108700005077 Viral Genes Proteins 0.000 description 8
• 125000000539 amino acid group Chemical group 0.000 description 8
• 239000002502 liposome Substances 0.000 description 8
• 230000037361 pathway Effects 0.000 description 8
• 239000000047 product Substances 0.000 description 8
• 230000001105 regulatory effect Effects 0.000 description 8
• 239000002904 solvent Substances 0.000 description 8
• 241000699670 Mus sp. Species 0.000 description 7
• 208000001089 Multiple system atrophy Diseases 0.000 description 6
• 108091081062 Repeated sequence (DNA) Proteins 0.000 description 6
• 102000006275 Ubiquitin-Protein Ligases Human genes 0.000 description 6
• 108010083111 Ubiquitin-Protein Ligases Proteins 0.000 description 6
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 6
• 125000002091 cationic group Chemical group 0.000 description 6
• 230000007812 deficiency Effects 0.000 description 6
• 239000003623 enhancer Substances 0.000 description 6
• 230000002255 enzymatic effect Effects 0.000 description 6
• 238000002347 injection Methods 0.000 description 6
• 239000007924 injection Substances 0.000 description 6
• 238000002360 preparation method Methods 0.000 description 6
• 201000002212 progressive supranuclear palsy Diseases 0.000 description 6
• 230000002463 transducing effect Effects 0.000 description 6
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
• 239000000080 wetting agent Substances 0.000 description 6
• 102100022641 Coagulation factor IX Human genes 0.000 description 5
• 102000004190 Enzymes Human genes 0.000 description 5
• 108090000790 Enzymes Proteins 0.000 description 5
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
• 208000015872 Gaucher disease Diseases 0.000 description 5
• 230000037396 body weight Effects 0.000 description 5
• 239000000872 buffer Substances 0.000 description 5
• 239000002775 capsule Substances 0.000 description 5
• 210000003169 central nervous system Anatomy 0.000 description 5
• 238000000576 coating method Methods 0.000 description 5
• 230000003247 decreasing effect Effects 0.000 description 5
• 230000002950 deficient Effects 0.000 description 5
• 108020004999 messenger RNA Proteins 0.000 description 5
• 239000006187 pill Substances 0.000 description 5
• 230000008488 polyadenylation Effects 0.000 description 5
• 229920001223 polyethylene glycol Polymers 0.000 description 5
• 239000007909 solid dosage form Substances 0.000 description 5
• 239000003826 tablet Substances 0.000 description 5
• 241000701447 unidentified baculovirus Species 0.000 description 5
• PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 4
• 102000010170 Death domains Human genes 0.000 description 4
• 108050001718 Death domains Proteins 0.000 description 4
• 201000011240 Frontotemporal dementia Diseases 0.000 description 4
• 241000713813 Gibbon ape leukemia virus Species 0.000 description 4
• 102000003886 Glycoproteins Human genes 0.000 description 4
• 108090000288 Glycoproteins Proteins 0.000 description 4
• 208000009292 Hemophilia A Diseases 0.000 description 4
• 208000023105 Huntington disease Diseases 0.000 description 4
• 108010072621 Interleukin-1 Receptor-Associated Kinases Proteins 0.000 description 4
• 102000006940 Interleukin-1 Receptor-Associated Kinases Human genes 0.000 description 4
• 241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 4
• 208000027933 Mannosidase Deficiency disease Diseases 0.000 description 4
• 201000011442 Metachromatic leukodystrophy Diseases 0.000 description 4
• 208000018737 Parkinson disease Diseases 0.000 description 4
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
• 241000713325 Visna/maedi virus Species 0.000 description 4
• 230000033289 adaptive immune response Effects 0.000 description 4
• 238000013459 approach Methods 0.000 description 4
• 230000015556 catabolic process Effects 0.000 description 4
• 230000000295 complement effect Effects 0.000 description 4
• 238000006731 degradation reaction Methods 0.000 description 4
• 230000037430 deletion Effects 0.000 description 4
• 238000012217 deletion Methods 0.000 description 4
• 239000003085 diluting agent Substances 0.000 description 4
• 239000002552 dosage form Substances 0.000 description 4
• 230000004064 dysfunction Effects 0.000 description 4
• 238000001914 filtration Methods 0.000 description 4
• 238000003306 harvesting Methods 0.000 description 4
• 238000001727 in vivo Methods 0.000 description 4
• 239000003701 inert diluent Substances 0.000 description 4
• 101150066555 lacZ gene Proteins 0.000 description 4
• 239000008101 lactose Substances 0.000 description 4
• 239000007788 liquid Substances 0.000 description 4
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
• 239000003550 marker Substances 0.000 description 4
• 201000006938 muscular dystrophy Diseases 0.000 description 4
• 150000003904 phospholipids Chemical class 0.000 description 4
• 229920000642 polymer Polymers 0.000 description 4
• 101150066583 rep gene Proteins 0.000 description 4
• 230000004044 response Effects 0.000 description 4
• 238000002560 therapeutic procedure Methods 0.000 description 4
• 238000013518 transcription Methods 0.000 description 4
• 230000035897 transcription Effects 0.000 description 4
• 238000011277 treatment modality Methods 0.000 description 4
• MWRBNPKJOOWZPW-NYVOMTAGSA-N 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine zwitterion Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP(O)(=O)OCCN)OC(=O)CCCCCCC\C=C/CCCCCCCC MWRBNPKJOOWZPW-NYVOMTAGSA-N 0.000 description 3
• LDGWQMRUWMSZIU-LQDDAWAPSA-M 2,3-bis[(z)-octadec-9-enoxy]propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCCOCC(C[N+](C)(C)C)OCCCCCCCC\C=C/CCCCCCCC LDGWQMRUWMSZIU-LQDDAWAPSA-M 0.000 description 3
• 102100024643 ATP-binding cassette sub-family D member 1 Human genes 0.000 description 3
• 102100026882 Alpha-synuclein Human genes 0.000 description 3
• 102100022548 Beta-hexosaminidase subunit alpha Human genes 0.000 description 3
• 208000003174 Brain Neoplasms Diseases 0.000 description 3
• 102000053602 DNA Human genes 0.000 description 3
• 102000001039 Dystrophin Human genes 0.000 description 3
• 108010069091 Dystrophin Proteins 0.000 description 3
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
• 108010076282 Factor IX Proteins 0.000 description 3
• 102000001690 Factor VIII Human genes 0.000 description 3
• 108010054218 Factor VIII Proteins 0.000 description 3
• 208000032007 Glycogen storage disease due to acid maltase deficiency Diseases 0.000 description 3
• 206010053185 Glycogen storage disease type II Diseases 0.000 description 3
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
• 241000713326 Jaagsiekte sheep retrovirus Species 0.000 description 3
• 102100033448 Lysosomal alpha-glucosidase Human genes 0.000 description 3
• 108010049137 Member 1 Subfamily D ATP Binding Cassette Transporter Proteins 0.000 description 3
• 108010077432 Myeloid Differentiation Factor 88 Proteins 0.000 description 3
• 102000010168 Myeloid Differentiation Factor 88 Human genes 0.000 description 3
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
• 108010069013 Phenylalanine Hydroxylase Proteins 0.000 description 3
• 102100038223 Phenylalanine-4-hydroxylase Human genes 0.000 description 3
• 102100028251 Phosphoglycerate kinase 1 Human genes 0.000 description 3
• 101710139464 Phosphoglycerate kinase 1 Proteins 0.000 description 3
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
• 108010034546 Serratia marcescens nuclease Proteins 0.000 description 3
• 229920002472 Starch Polymers 0.000 description 3
• 229930006000 Sucrose Natural products 0.000 description 3
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
• 108010021188 Superoxide Dismutase-1 Proteins 0.000 description 3
• 102100038836 Superoxide dismutase [Cu-Zn] Human genes 0.000 description 3
• 230000002159 abnormal effect Effects 0.000 description 3
• 206010064930 age-related macular degeneration Diseases 0.000 description 3
• 102000015395 alpha 1-Antitrypsin Human genes 0.000 description 3
• 108010050122 alpha 1-Antitrypsin Proteins 0.000 description 3
• 229940024142 alpha 1-antitrypsin Drugs 0.000 description 3
• 108090000185 alpha-Synuclein Proteins 0.000 description 3
• 210000004507 artificial chromosome Anatomy 0.000 description 3
• 238000003556 assay Methods 0.000 description 3
• 210000003719 b-lymphocyte Anatomy 0.000 description 3
• 239000001506 calcium phosphate Substances 0.000 description 3
• 239000000969 carrier Substances 0.000 description 3
• 230000001413 cellular effect Effects 0.000 description 3
• 230000007541 cellular toxicity Effects 0.000 description 3
• 238000004587 chromatography analysis Methods 0.000 description 3
• 210000000349 chromosome Anatomy 0.000 description 3
• 238000010367 cloning Methods 0.000 description 3
• 238000011278 co-treatment Methods 0.000 description 3
• 239000000356 contaminant Substances 0.000 description 3
• 230000004069 differentiation Effects 0.000 description 3
• 239000003937 drug carrier Substances 0.000 description 3
• 239000003995 emulsifying agent Substances 0.000 description 3
• 239000000839 emulsion Substances 0.000 description 3
• 229960004222 factor ix Drugs 0.000 description 3
• 229960000301 factor viii Drugs 0.000 description 3
• 239000000945 filler Substances 0.000 description 3
• 201000004502 glycogen storage disease II Diseases 0.000 description 3
• 239000008187 granular material Substances 0.000 description 3
• 239000003018 immunosuppressive agent Substances 0.000 description 3
• 230000002401 inhibitory effect Effects 0.000 description 3
• 230000014828 interferon-gamma production Effects 0.000 description 3
• 238000002955 isolation Methods 0.000 description 3
• 210000004185 liver Anatomy 0.000 description 3
• 208000002780 macular degeneration Diseases 0.000 description 3
• 238000012423 maintenance Methods 0.000 description 3
• 210000004962 mammalian cell Anatomy 0.000 description 3
• 239000000463 material Substances 0.000 description 3
• 239000002609 medium Substances 0.000 description 3
• 230000002503 metabolic effect Effects 0.000 description 3
• 210000002569 neuron Anatomy 0.000 description 3
• 239000000346 nonvolatile oil Substances 0.000 description 3
• 244000052769 pathogen Species 0.000 description 3
• XMRIUEGHBZTNND-UHFFFAOYSA-N pyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C1=CC=NC2=C(C(=O)N)C=NN21 XMRIUEGHBZTNND-UHFFFAOYSA-N 0.000 description 3
• 102000005962 receptors Human genes 0.000 description 3
• 108020003175 receptors Proteins 0.000 description 3
• 230000003362 replicative effect Effects 0.000 description 3
• 230000019491 signal transduction Effects 0.000 description 3
• 239000008247 solid mixture Substances 0.000 description 3
• 210000004988 splenocyte Anatomy 0.000 description 3
• 238000010561 standard procedure Methods 0.000 description 3
• 235000019698 starch Nutrition 0.000 description 3
• 230000000638 stimulation Effects 0.000 description 3
• 238000006467 substitution reaction Methods 0.000 description 3
• 239000005720 sucrose Substances 0.000 description 3
• 239000000375 suspending agent Substances 0.000 description 3
• 230000001988 toxicity Effects 0.000 description 3
• 231100000419 toxicity Toxicity 0.000 description 3
• 210000002845 virion Anatomy 0.000 description 3
• SNKAWJBJQDLSFF-NVKMUCNASA-N 1,2-dioleoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC SNKAWJBJQDLSFF-NVKMUCNASA-N 0.000 description 2
• VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
• FVBVEHVQVWFUKG-UMSGYPCISA-N 4-[[dithiocarboxy-[(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]benzoic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CN(C(S)=S)CC1=CC=C(C(O)=O)C=C1 FVBVEHVQVWFUKG-UMSGYPCISA-N 0.000 description 2
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
• 201000011452 Adrenoleukodystrophy Diseases 0.000 description 2
• 102100031317 Alpha-N-acetylgalactosaminidase Human genes 0.000 description 2
• 208000029602 Alpha-N-acetylgalactosaminidase deficiency Diseases 0.000 description 2
• 208000024827 Alzheimer disease Diseases 0.000 description 2
• 101710137189 Amyloid-beta A4 protein Proteins 0.000 description 2
• 102100022704 Amyloid-beta precursor protein Human genes 0.000 description 2
• 101710151993 Amyloid-beta precursor protein Proteins 0.000 description 2
• 101001073212 Arabidopsis thaliana Peroxidase 33 Proteins 0.000 description 2
• 206010003805 Autism Diseases 0.000 description 2
• 208000020706 Autistic disease Diseases 0.000 description 2
• 241000951889 Autographa californica multiple nucleopolyhedrovirus Species 0.000 description 2
• 241000713826 Avian leukosis virus Species 0.000 description 2
• 102100032487 Beta-mannosidase Human genes 0.000 description 2
• 241000713704 Bovine immunodeficiency virus Species 0.000 description 2
• VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
• 208000022526 Canavan disease Diseases 0.000 description 2
• 101150044789 Cap gene Proteins 0.000 description 2
• 241000713756 Caprine arthritis encephalitis virus Species 0.000 description 2
• 102100026735 Coagulation factor VIII Human genes 0.000 description 2
• 208000011990 Corticobasal Degeneration Diseases 0.000 description 2
• 206010012289 Dementia Diseases 0.000 description 2
• 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 description 2
• 241000713730 Equine infectious anemia virus Species 0.000 description 2
• 201000003542 Factor VIII deficiency Diseases 0.000 description 2
• 241000713800 Feline immunodeficiency virus Species 0.000 description 2
• 241000712469 Fowl plague virus Species 0.000 description 2
• 201000008892 GM1 Gangliosidosis Diseases 0.000 description 2
• 102000036509 GTP Cyclohydrolase Human genes 0.000 description 2
• 108010023555 GTP Cyclohydrolase Proteins 0.000 description 2
• 102100028496 Galactocerebrosidase Human genes 0.000 description 2
• 101000834253 Gallus gallus Actin, cytoplasmic 1 Proteins 0.000 description 2
• 208000037310 Gaucher disease type 2 Diseases 0.000 description 2
• 208000037311 Gaucher disease type 3 Diseases 0.000 description 2
• 208000010055 Globoid Cell Leukodystrophy Diseases 0.000 description 2
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
• 102000004547 Glucosylceramidase Human genes 0.000 description 2
• 108010017544 Glucosylceramidase Proteins 0.000 description 2
• 102000053187 Glucuronidase Human genes 0.000 description 2
• 108010060309 Glucuronidase Proteins 0.000 description 2
• 229920002683 Glycosaminoglycan Polymers 0.000 description 2
• 208000031220 Hemophilia Diseases 0.000 description 2
• 241000711549 Hepacivirus C Species 0.000 description 2
• 208000009889 Herpes Simplex Diseases 0.000 description 2
• 241000238631 Hexapoda Species 0.000 description 2
• 108010000540 Hexosaminidases Proteins 0.000 description 2
• 102000002268 Hexosaminidases Human genes 0.000 description 2
• 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 2
• 101001123325 Homo sapiens Peroxisome proliferator-activated receptor gamma coactivator 1-beta Proteins 0.000 description 2
• 101000620777 Homo sapiens Rab proteins geranylgeranyltransferase component A 1 Proteins 0.000 description 2
• 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 description 2
• 101000831496 Homo sapiens Toll-like receptor 3 Proteins 0.000 description 2
• 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 description 2
• 241000714260 Human T-lymphotropic virus 1 Species 0.000 description 2
• 241001135569 Human adenovirus 5 Species 0.000 description 2
• 241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 2
• XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 2
• 102100029199 Iduronate 2-sulfatase Human genes 0.000 description 2
• 108010002352 Interleukin-1 Proteins 0.000 description 2
• 102000000589 Interleukin-1 Human genes 0.000 description 2
• 241001505307 Jembrana disease virus Species 0.000 description 2
• 208000028226 Krabbe disease Diseases 0.000 description 2
• 102100022745 Laminin subunit alpha-2 Human genes 0.000 description 2
• 102100033342 Lysosomal acid glucosylceramidase Human genes 0.000 description 2
• 102100026001 Lysosomal acid lipase/cholesteryl ester hydrolase Human genes 0.000 description 2
• 102100024295 Maltase-glucoamylase Human genes 0.000 description 2
• 241001480512 Mammalian orthoreovirus 3 Species 0.000 description 2
• 241000702623 Minute virus of mice Species 0.000 description 2
• 241000713869 Moloney murine leukemia virus Species 0.000 description 2
• 206010056893 Mucopolysaccharidosis VII Diseases 0.000 description 2
• 102100023282 N-acetylglucosamine-6-sulfatase Human genes 0.000 description 2
• 102100027661 N-sulphoglucosamine sulphohydrolase Human genes 0.000 description 2
• 206010028980 Neoplasm Diseases 0.000 description 2
• 102000007981 Ornithine carbamoyltransferase Human genes 0.000 description 2
• 101710198224 Ornithine carbamoyltransferase, mitochondrial Proteins 0.000 description 2
• 241000283973 Oryctolagus cuniculus Species 0.000 description 2
• 102100028961 Peroxisome proliferator-activated receptor gamma coactivator 1-beta Human genes 0.000 description 2
• 201000011252 Phenylketonuria Diseases 0.000 description 2
• 239000002202 Polyethylene glycol Substances 0.000 description 2
• 241000288906 Primates Species 0.000 description 2
• 101710149951 Protein Tat Proteins 0.000 description 2
• 102100022881 Rab proteins geranylgeranyltransferase component A 1 Human genes 0.000 description 2
• 101100409194 Rattus norvegicus Ppargc1b gene Proteins 0.000 description 2
• 102100031176 Retinoid isomerohydrolase Human genes 0.000 description 2
• 208000021811 Sandhoff disease Diseases 0.000 description 2
• 241000710961 Semliki Forest virus Species 0.000 description 2
• 241000713311 Simian immunodeficiency virus Species 0.000 description 2
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
• 241000701093 Suid alphaherpesvirus 1 Species 0.000 description 2
• 102100021947 Survival motor neuron protein Human genes 0.000 description 2
• 101710171779 Survival motor neuron protein Proteins 0.000 description 2
• 208000022292 Tay-Sachs disease Diseases 0.000 description 2
• 102100024333 Toll-like receptor 2 Human genes 0.000 description 2
• 102100024324 Toll-like receptor 3 Human genes 0.000 description 2
• 102100039360 Toll-like receptor 4 Human genes 0.000 description 2
• 208000030886 Traumatic Brain injury Diseases 0.000 description 2
• 108700001567 Type I Schindler Disease Proteins 0.000 description 2
• 208000026589 Wolman disease Diseases 0.000 description 2
• LDGWQMRUWMSZIU-YKBXHWKCSA-M [Cl-].CCCCCCCC\C=C/CCCCCCCCOC[C@@H](C[N+](C)(C)C)OCCCCCCCC\C=C/CCCCCCCC Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCCOC[C@@H](C[N+](C)(C)C)OCCCCCCCC\C=C/CCCCCCCC LDGWQMRUWMSZIU-YKBXHWKCSA-M 0.000 description 2
• 239000002253 acid Substances 0.000 description 2
• 239000004480 active ingredient Substances 0.000 description 2
• 230000001154 acute effect Effects 0.000 description 2
• 230000004721 adaptive immunity Effects 0.000 description 2
• 235000010443 alginic acid Nutrition 0.000 description 2
• 229920000615 alginic acid Polymers 0.000 description 2
• 235000001014 amino acid Nutrition 0.000 description 2
• DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 description 2
• 238000004458 analytical method Methods 0.000 description 2
• 125000000129 anionic group Chemical group 0.000 description 2
• 230000000692 anti-sense effect Effects 0.000 description 2
• SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
• 230000001588 bifunctional effect Effects 0.000 description 2
• 108010006025 bovine growth hormone Proteins 0.000 description 2
• 239000006172 buffering agent Substances 0.000 description 2
• 235000019437 butane-1,3-diol Nutrition 0.000 description 2
• 229910000389 calcium phosphate Inorganic materials 0.000 description 2
• 235000011010 calcium phosphates Nutrition 0.000 description 2
• 201000011510 cancer Diseases 0.000 description 2
• 229910052799 carbon Inorganic materials 0.000 description 2
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
• 208000003571 choroideremia Diseases 0.000 description 2
• 208000010877 cognitive disease Diseases 0.000 description 2
• 201000006815 congenital muscular dystrophy Diseases 0.000 description 2
• 238000009295 crossflow filtration Methods 0.000 description 2
• 230000003013 cytotoxicity Effects 0.000 description 2
• 231100000135 cytotoxicity Toxicity 0.000 description 2
• 230000007423 decrease Effects 0.000 description 2
• 230000007547 defect Effects 0.000 description 2
• 230000007850 degeneration Effects 0.000 description 2
• 230000003111 delayed effect Effects 0.000 description 2
• 230000001419 dependent effect Effects 0.000 description 2
• 235000014113 dietary fatty acids Nutrition 0.000 description 2
• 239000002270 dispersing agent Substances 0.000 description 2
• 239000008298 dragée Substances 0.000 description 2
• 239000012636 effector Substances 0.000 description 2
• 230000008030 elimination Effects 0.000 description 2
• 238000003379 elimination reaction Methods 0.000 description 2
• 239000002702 enteric coating Substances 0.000 description 2
• 238000009505 enteric coating Methods 0.000 description 2
• 206010015037 epilepsy Diseases 0.000 description 2
• 235000019441 ethanol Nutrition 0.000 description 2
• 238000002474 experimental method Methods 0.000 description 2
• 239000000194 fatty acid Substances 0.000 description 2
• 229930195729 fatty acid Natural products 0.000 description 2
• 201000005206 focal segmental glomerulosclerosis Diseases 0.000 description 2
• 231100000854 focal segmental glomerulosclerosis Toxicity 0.000 description 2
• 239000012634 fragment Substances 0.000 description 2
• 108700004026 gag Genes Proteins 0.000 description 2
• 230000000574 ganglionic effect Effects 0.000 description 2
• 210000001035 gastrointestinal tract Anatomy 0.000 description 2
• 239000007903 gelatin capsule Substances 0.000 description 2
• 238000003197 gene knockdown Methods 0.000 description 2
• 231100000024 genotoxic Toxicity 0.000 description 2
• 230000001738 genotoxic effect Effects 0.000 description 2
• 208000009429 hemophilia B Diseases 0.000 description 2
• 210000005260 human cell Anatomy 0.000 description 2
• 230000036039 immunity Effects 0.000 description 2
• 230000002779 inactivation Effects 0.000 description 2
• 208000016245 inborn errors of metabolism Diseases 0.000 description 2
• 239000004615 ingredient Substances 0.000 description 2
• 208000015978 inherited metabolic disease Diseases 0.000 description 2
• 230000005764 inhibitory process Effects 0.000 description 2
• 229940102223 injectable solution Drugs 0.000 description 2
• 229940102213 injectable suspension Drugs 0.000 description 2
• 230000002452 interceptive effect Effects 0.000 description 2
• 238000007918 intramuscular administration Methods 0.000 description 2
• 238000007913 intrathecal administration Methods 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• 239000000644 isotonic solution Substances 0.000 description 2
• 208000036546 leukodystrophy Diseases 0.000 description 2
• 239000003446 ligand Substances 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 230000037356 lipid metabolism Effects 0.000 description 2
• 239000002479 lipoplex Substances 0.000 description 2
• 239000008297 liquid dosage form Substances 0.000 description 2
• 239000000314 lubricant Substances 0.000 description 2
• 210000004072 lung Anatomy 0.000 description 2
• 230000002132 lysosomal effect Effects 0.000 description 2
• 235000019359 magnesium stearate Nutrition 0.000 description 2
• 239000012092 media component Substances 0.000 description 2
• 210000003071 memory t lymphocyte Anatomy 0.000 description 2
• 239000002207 metabolite Substances 0.000 description 2
• 230000003278 mimic effect Effects 0.000 description 2
• 230000004048 modification Effects 0.000 description 2
• 238000012986 modification Methods 0.000 description 2
• 208000005340 mucopolysaccharidosis III Diseases 0.000 description 2
• 208000025919 mucopolysaccharidosis type 7 Diseases 0.000 description 2
• 210000000822 natural killer cell Anatomy 0.000 description 2
• 230000004770 neurodegeneration Effects 0.000 description 2
• 208000015122 neurodegenerative disease Diseases 0.000 description 2
• 230000007935 neutral effect Effects 0.000 description 2
• 231100000252 nontoxic Toxicity 0.000 description 2
• 230000003000 nontoxic effect Effects 0.000 description 2
• 239000003921 oil Substances 0.000 description 2
• 235000019198 oils Nutrition 0.000 description 2
• 239000005022 packaging material Substances 0.000 description 2
• 230000007331 pathological accumulation Effects 0.000 description 2
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
• 230000035790 physiological processes and functions Effects 0.000 description 2
• 108700004029 pol Genes Proteins 0.000 description 2
• 208000020016 psychiatric disease Diseases 0.000 description 2
• 238000000746 purification Methods 0.000 description 2
• RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 2
• 230000002829 reductive effect Effects 0.000 description 2
• 108700004030 rev Genes Proteins 0.000 description 2
• 230000002441 reversible effect Effects 0.000 description 2
• 238000001542 size-exclusion chromatography Methods 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• 239000007787 solid Substances 0.000 description 2
• 210000000952 spleen Anatomy 0.000 description 2
• 239000003381 stabilizer Substances 0.000 description 2
• 239000008107 starch Substances 0.000 description 2
• 238000007920 subcutaneous administration Methods 0.000 description 2
• 235000000346 sugar Nutrition 0.000 description 2
• 239000006228 supernatant Substances 0.000 description 2
• 208000011580 syndromic disease Diseases 0.000 description 2
• 230000002194 synthesizing effect Effects 0.000 description 2
• 230000008685 targeting Effects 0.000 description 2
• 230000005100 tissue tropism Effects 0.000 description 2
• 238000012546 transfer Methods 0.000 description 2
• 238000013519 translation Methods 0.000 description 2
• 230000009529 traumatic brain injury Effects 0.000 description 2
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
• 241001529453 unidentified herpesvirus Species 0.000 description 2
• 241001430294 unidentified retrovirus Species 0.000 description 2
• 239000003981 vehicle Substances 0.000 description 2
• 239000001993 wax Substances 0.000 description 2
• 238000009736 wetting Methods 0.000 description 2
• JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
• WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
• 229940058015 1,3-butylene glycol Drugs 0.000 description 1
• LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
• 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 description 1
• QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
• 102100032534 Adenosine kinase Human genes 0.000 description 1
• 108010076278 Adenosine kinase Proteins 0.000 description 1
• 229920001817 Agar Polymers 0.000 description 1
• 102100034561 Alpha-N-acetylglucosaminidase Human genes 0.000 description 1
• 239000005995 Aluminium silicate Substances 0.000 description 1
• 235000003276 Apios tuberosa Nutrition 0.000 description 1
• 244000105624 Arachis hypogaea Species 0.000 description 1
• 235000010777 Arachis hypogaea Nutrition 0.000 description 1
• 235000010744 Arachis villosulicarpa Nutrition 0.000 description 1
• 102000053640 Argininosuccinate synthases Human genes 0.000 description 1
• 108700024106 Argininosuccinate synthases Proteins 0.000 description 1
• 102000009133 Arylsulfatases Human genes 0.000 description 1
• 241000201370 Autographa californica nucleopolyhedrovirus Species 0.000 description 1
• 241000271566 Aves Species 0.000 description 1
• 102000004072 Beclin-1 Human genes 0.000 description 1
• 108090000524 Beclin-1 Proteins 0.000 description 1
• 102100026189 Beta-galactosidase Human genes 0.000 description 1
• 101710195294 Beta-galactosidase 1 Proteins 0.000 description 1
• 102100026031 Beta-glucuronidase Human genes 0.000 description 1
• 102100022549 Beta-hexosaminidase subunit beta Human genes 0.000 description 1
• 229920002799 BoPET Polymers 0.000 description 1
• 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 1
• 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 1
• 101710117545 C protein Proteins 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
• 108010078791 Carrier Proteins Proteins 0.000 description 1
• 102000003952 Caspase 3 Human genes 0.000 description 1
• 108090000397 Caspase 3 Proteins 0.000 description 1
• 241000711969 Chandipura virus Species 0.000 description 1
• 208000033810 Choroidal dystrophy Diseases 0.000 description 1
• 201000011297 Citrullinemia Diseases 0.000 description 1
• 108020004705 Codon Proteins 0.000 description 1
• 108091035707 Consensus sequence Proteins 0.000 description 1
• 206010011778 Cystinuria Diseases 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• 230000004543 DNA replication Effects 0.000 description 1
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
• 108010053770 Deoxyribonucleases Proteins 0.000 description 1
• 102000016911 Deoxyribonucleases Human genes 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• 206010012689 Diabetic retinopathy Diseases 0.000 description 1
• 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
• UPEZCKBFRMILAV-JNEQICEOSA-N Ecdysone Natural products O=C1[C@H]2[C@@](C)([C@@H]3C([C@@]4(O)[C@@](C)([C@H]([C@H]([C@@H](O)CCC(O)(C)C)C)CC4)CC3)=C1)C[C@H](O)[C@H](O)C2 UPEZCKBFRMILAV-JNEQICEOSA-N 0.000 description 1
• 102100027723 Endogenous retrovirus group K member 6 Rec protein Human genes 0.000 description 1
• 101710091045 Envelope protein Proteins 0.000 description 1
• 241000282324 Felis Species 0.000 description 1
• 239000004606 Fillers/Extenders Substances 0.000 description 1
• 108010042681 Galactosylceramidase Proteins 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• 241000206672 Gelidium Species 0.000 description 1
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
• 208000010412 Glaucoma Diseases 0.000 description 1
• 102000034615 Glial cell line-derived neurotrophic factor Human genes 0.000 description 1
• 108091010837 Glial cell line-derived neurotrophic factor Proteins 0.000 description 1
• 102100021519 Hemoglobin subunit beta Human genes 0.000 description 1
• 108091005904 Hemoglobin subunit beta Proteins 0.000 description 1
• 208000032087 Hereditary Leber Optic Atrophy Diseases 0.000 description 1
• 239000004705 High-molecular-weight polyethylene Substances 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 101000765010 Homo sapiens Beta-galactosidase Proteins 0.000 description 1
• 101000933465 Homo sapiens Beta-glucuronidase Proteins 0.000 description 1
• 101001045433 Homo sapiens Beta-hexosaminidase subunit beta Proteins 0.000 description 1
• 101000860395 Homo sapiens Galactocerebrosidase Proteins 0.000 description 1
• 101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 description 1
• 101000979046 Homo sapiens Lysosomal alpha-mannosidase Proteins 0.000 description 1
• 101001052076 Homo sapiens Maltase-glucoamylase Proteins 0.000 description 1
• 101001072470 Homo sapiens N-acetylglucosamine-1-phosphotransferase subunits alpha/beta Proteins 0.000 description 1
• 101000651201 Homo sapiens N-sulphoglucosamine sulphohydrolase Proteins 0.000 description 1
• 101001098529 Homo sapiens Proteinase-activated receptor 1 Proteins 0.000 description 1
• 101000729271 Homo sapiens Retinoid isomerohydrolase Proteins 0.000 description 1
• 101000835998 Homo sapiens SRA stem-loop-interacting RNA-binding protein, mitochondrial Proteins 0.000 description 1
• 101000631760 Homo sapiens Sodium channel protein type 1 subunit alpha Proteins 0.000 description 1
• 101000713169 Homo sapiens Solute carrier family 52, riboflavin transporter, member 2 Proteins 0.000 description 1
• 241000713673 Human foamy virus Species 0.000 description 1
• 241000713340 Human immunodeficiency virus 2 Species 0.000 description 1
• 241000712003 Human respirovirus 3 Species 0.000 description 1
• CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
• GRRNUXAQVGOGFE-UHFFFAOYSA-N Hygromycin-B Natural products OC1C(NC)CC(N)C(O)C1OC1C2OC3(C(C(O)C(O)C(C(N)CO)O3)O)OC2C(O)C(CO)O1 GRRNUXAQVGOGFE-UHFFFAOYSA-N 0.000 description 1
• 101150090364 ICP0 gene Proteins 0.000 description 1
• 101150027427 ICP4 gene Proteins 0.000 description 1
• 101150106931 IFNG gene Proteins 0.000 description 1
• 101710096421 Iduronate 2-sulfatase Proteins 0.000 description 1
• 102000019223 Interleukin-1 receptor Human genes 0.000 description 1
• 108050006617 Interleukin-1 receptor Proteins 0.000 description 1
• AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
• 241000712902 Lassa mammarenavirus Species 0.000 description 1
• 201000003533 Leber congenital amaurosis Diseases 0.000 description 1
• 201000000639 Leber hereditary optic neuropathy Diseases 0.000 description 1
• 240000007472 Leucaena leucocephala Species 0.000 description 1
• 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
• 239000000232 Lipid Bilayer Substances 0.000 description 1
• 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 1
• 102100023231 Lysosomal alpha-mannosidase Human genes 0.000 description 1
• JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
• 240000003183 Manihot esculenta Species 0.000 description 1
• 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 108010054377 Mannosidases Proteins 0.000 description 1
• 102000001696 Mannosidases Human genes 0.000 description 1
• 241001465754 Metazoa Species 0.000 description 1
• 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
• 241000725171 Mokola lyssavirus Species 0.000 description 1
• 241000713333 Mouse mammary tumor virus Species 0.000 description 1
• 241000714177 Murine leukemia virus Species 0.000 description 1
• 241000711408 Murine respirovirus Species 0.000 description 1
• 239000005041 Mylar™ Substances 0.000 description 1
• 102000004128 Myotubularin Human genes 0.000 description 1
• 108090000697 Myotubularin Proteins 0.000 description 1
• 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 description 1
• 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 description 1
• 102100036710 N-acetylglucosamine-1-phosphotransferase subunits alpha/beta Human genes 0.000 description 1
• 108010023320 N-acetylglucosamine-6-sulfatase Proteins 0.000 description 1
• 101710202061 N-acetyltransferase Proteins 0.000 description 1
• 108010006140 N-sulfoglucosamine sulfohydrolase Proteins 0.000 description 1
• 102100021506 NADH-ubiquinone oxidoreductase chain 4 Human genes 0.000 description 1
• 101710106576 NADH-ubiquinone oxidoreductase chain 4 Proteins 0.000 description 1
• 108091005461 Nucleic proteins Proteins 0.000 description 1
• 240000007817 Olea europaea Species 0.000 description 1
• 239000005642 Oleic acid Substances 0.000 description 1
• ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
• 102000015636 Oligopeptides Human genes 0.000 description 1
• 108010038807 Oligopeptides Proteins 0.000 description 1
• 108700020796 Oncogene Proteins 0.000 description 1
• 208000001388 Opportunistic Infections Diseases 0.000 description 1
• AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
• UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
• 238000012408 PCR amplification Methods 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 235000019483 Peanut oil Nutrition 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 102000010292 Peptide Elongation Factor 1 Human genes 0.000 description 1
• 108010077524 Peptide Elongation Factor 1 Proteins 0.000 description 1
• 108091000080 Phosphotransferase Proteins 0.000 description 1
• 108010071690 Prealbumin Proteins 0.000 description 1
• XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 1
• 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 1
• 101710188315 Protein X Proteins 0.000 description 1
• 241000125945 Protoparvovirus Species 0.000 description 1
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
• 108091034057 RNA (poly(A)) Proteins 0.000 description 1
• 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 1
• 206010037742 Rabies Diseases 0.000 description 1
• 208000037340 Rare genetic disease Diseases 0.000 description 1
• 102000018120 Recombinases Human genes 0.000 description 1
• 108010091086 Recombinases Proteins 0.000 description 1
• 241001115394 Reston ebolavirus Species 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• 235000004443 Ricinus communis Nutrition 0.000 description 1
• 241000714474 Rous sarcoma virus Species 0.000 description 1
• 241000315672 SARS coronavirus Species 0.000 description 1
• 102100025491 SRA stem-loop-interacting RNA-binding protein, mitochondrial Human genes 0.000 description 1
• 208000025816 Sanfilippo syndrome type A Diseases 0.000 description 1
• 208000025802 Sanfilippo syndrome type C Diseases 0.000 description 1
• 241000710960 Sindbis virus Species 0.000 description 1
• 102100028910 Sodium channel protein type 1 subunit alpha Human genes 0.000 description 1
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
• 244000061456 Solanum tuberosum Species 0.000 description 1
• 235000002595 Solanum tuberosum Nutrition 0.000 description 1
• 102100036862 Solute carrier family 52, riboflavin transporter, member 2 Human genes 0.000 description 1
• 108010061312 Sphingomyelin Phosphodiesterase Proteins 0.000 description 1
• 241000251131 Sphyrna Species 0.000 description 1
• 241000256251 Spodoptera frugiperda Species 0.000 description 1
• SSZBUIDZHHWXNJ-UHFFFAOYSA-N Stearinsaeure-hexadecylester Natural products CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC SSZBUIDZHHWXNJ-UHFFFAOYSA-N 0.000 description 1
• 108010055297 Sterol Esterase Proteins 0.000 description 1
• 208000006011 Stroke Diseases 0.000 description 1
• 208000032978 Structural Congenital Myopathies Diseases 0.000 description 1
• 108010017842 Telomerase Proteins 0.000 description 1
• 239000004098 Tetracycline Substances 0.000 description 1
• 108010022394 Threonine synthase Proteins 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• 102000009190 Transthyretin Human genes 0.000 description 1
• 108010044965 UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase Proteins 0.000 description 1
• 241000700618 Vaccinia virus Species 0.000 description 1
• 206010046865 Vaccinia virus infection Diseases 0.000 description 1
• 241000710959 Venezuelan equine encephalitis virus Species 0.000 description 1
• 108020005202 Viral DNA Proteins 0.000 description 1
• 108010067390 Viral Proteins Proteins 0.000 description 1
• 208000025033 X-linked centronuclear myopathy Diseases 0.000 description 1
• 240000008042 Zea mays Species 0.000 description 1
• 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
• 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
• 108010084455 Zeocin Proteins 0.000 description 1
• 239000001089 [(2R)-oxolan-2-yl]methanol Substances 0.000 description 1
• 239000002250 absorbent Substances 0.000 description 1
• 230000002745 absorbent Effects 0.000 description 1
• 239000003655 absorption accelerator Substances 0.000 description 1
• 150000001242 acetic acid derivatives Chemical class 0.000 description 1
• ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 1
• 230000021736 acetylation Effects 0.000 description 1
• 238000006640 acetylation reaction Methods 0.000 description 1
• 102000010126 acid sphingomyelin phosphodiesterase activity proteins Human genes 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 230000004913 activation Effects 0.000 description 1
• 208000038016 acute inflammation Diseases 0.000 description 1
• 230000006022 acute inflammation Effects 0.000 description 1
• 230000003044 adaptive effect Effects 0.000 description 1
• 210000005006 adaptive immune system Anatomy 0.000 description 1
• 108091005764 adaptor proteins Proteins 0.000 description 1
• 102000035181 adaptor proteins Human genes 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 238000001042 affinity chromatography Methods 0.000 description 1
• 235000010419 agar Nutrition 0.000 description 1
• 239000000556 agonist Substances 0.000 description 1
• 239000000783 alginic acid Substances 0.000 description 1
• 229960001126 alginic acid Drugs 0.000 description 1
• 150000004781 alginic acids Chemical class 0.000 description 1
• UPEZCKBFRMILAV-UHFFFAOYSA-N alpha-Ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C(O)CCC(C)(C)O)C)CCC33O)C)C3=CC(=O)C21 UPEZCKBFRMILAV-UHFFFAOYSA-N 0.000 description 1
• 108010028144 alpha-Glucosidases Proteins 0.000 description 1
• 108010012864 alpha-Mannosidase Proteins 0.000 description 1
• 102000019199 alpha-Mannosidase Human genes 0.000 description 1
• 108010015684 alpha-N-Acetylgalactosaminidase Proteins 0.000 description 1
• 108010009380 alpha-N-acetyl-D-glucosaminidase Proteins 0.000 description 1
• 235000012211 aluminium silicate Nutrition 0.000 description 1
• 239000003708 ampul Substances 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 238000000137 annealing Methods 0.000 description 1
• 239000005557 antagonist Substances 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000000840 anti-viral effect Effects 0.000 description 1
• 239000002518 antifoaming agent Substances 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 229910052586 apatite Inorganic materials 0.000 description 1
• 230000001580 bacterial effect Effects 0.000 description 1
• 210000003651 basophil Anatomy 0.000 description 1
• 239000011324 bead Substances 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• 239000000440 bentonite Substances 0.000 description 1
• 229910000278 bentonite Inorganic materials 0.000 description 1
• SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
• 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
• 229960002903 benzyl benzoate Drugs 0.000 description 1
• 208000005980 beta thalassemia Diseases 0.000 description 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
• 108010055059 beta-Mannosidase Proteins 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 230000003115 biocidal effect Effects 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 230000015572 biosynthetic process Effects 0.000 description 1
• 229930189065 blasticidin Natural products 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 108010046910 brain-derived growth factor Proteins 0.000 description 1
• 210000004899 c-terminal region Anatomy 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910000019 calcium carbonate Inorganic materials 0.000 description 1
• 235000010216 calcium carbonate Nutrition 0.000 description 1
• 229910001424 calcium ion Inorganic materials 0.000 description 1
• CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
• 235000013539 calcium stearate Nutrition 0.000 description 1
• 239000008116 calcium stearate Substances 0.000 description 1
• 239000001768 carboxy methyl cellulose Substances 0.000 description 1
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
• 239000012876 carrier material Substances 0.000 description 1
• 239000004359 castor oil Substances 0.000 description 1
• 229920006317 cationic polymer Polymers 0.000 description 1
• 230000024245 cell differentiation Effects 0.000 description 1
• 210000000170 cell membrane Anatomy 0.000 description 1
• 238000002659 cell therapy Methods 0.000 description 1
• 230000004700 cellular uptake Effects 0.000 description 1
• 229920002301 cellulose acetate Polymers 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 208000013896 centronuclear myopathy X-linked Diseases 0.000 description 1
• 229960000541 cetyl alcohol Drugs 0.000 description 1
• 235000012000 cholesterol Nutrition 0.000 description 1
• 208000016617 citrullinemia type I Diseases 0.000 description 1
• 238000005352 clarification Methods 0.000 description 1
• 239000008395 clarifying agent Substances 0.000 description 1
• 239000004927 clay Substances 0.000 description 1
• 238000003776 cleavage reaction Methods 0.000 description 1
• 239000002299 complementary DNA Substances 0.000 description 1
• 230000009918 complex formation Effects 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 235000005822 corn Nutrition 0.000 description 1
• 235000012343 cottonseed oil Nutrition 0.000 description 1
• 239000012228 culture supernatant Substances 0.000 description 1
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
• 235000018417 cysteine Nutrition 0.000 description 1
• 230000009089 cytolysis Effects 0.000 description 1
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
• 230000001934 delay Effects 0.000 description 1
• 238000002716 delivery method Methods 0.000 description 1
• 239000005547 deoxyribonucleotide Substances 0.000 description 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 230000001627 detrimental effect Effects 0.000 description 1
• UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
• 229960003957 dexamethasone Drugs 0.000 description 1
• 239000008121 dextrose Substances 0.000 description 1
• NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
• 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
• 229940038472 dicalcium phosphate Drugs 0.000 description 1
• 230000029087 digestion Effects 0.000 description 1
• 102000004419 dihydrofolate reductase Human genes 0.000 description 1
• 239000000539 dimer Substances 0.000 description 1
• 230000003292 diminished effect Effects 0.000 description 1
• 208000037765 diseases and disorders Diseases 0.000 description 1
• 238000004090 dissolution Methods 0.000 description 1
• 230000003828 downregulation Effects 0.000 description 1
• UPEZCKBFRMILAV-JMZLNJERSA-N ecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@H]([C@H](O)CCC(C)(C)O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 UPEZCKBFRMILAV-JMZLNJERSA-N 0.000 description 1
• 230000002526 effect on cardiovascular system Effects 0.000 description 1
• 238000004520 electroporation Methods 0.000 description 1
• 230000001804 emulsifying effect Effects 0.000 description 1
• 239000008393 encapsulating agent Substances 0.000 description 1
• 239000002158 endotoxin Substances 0.000 description 1
• 108010048367 enhanced green fluorescent protein Proteins 0.000 description 1
• 230000007613 environmental effect Effects 0.000 description 1
• 210000003979 eosinophil Anatomy 0.000 description 1
• 229940093499 ethyl acetate Drugs 0.000 description 1
• 150000004665 fatty acids Chemical class 0.000 description 1
• 239000000796 flavoring agent Substances 0.000 description 1
• 238000009459 flexible packaging Methods 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• 238000002825 functional assay Methods 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Natural products O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 1
• 230000002518 glial effect Effects 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 235000001727 glucose Nutrition 0.000 description 1
• YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
• SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
• 150000002334 glycols Chemical class 0.000 description 1
• 230000013595 glycosylation Effects 0.000 description 1
• 238000006206 glycosylation reaction Methods 0.000 description 1
• 230000012010 growth Effects 0.000 description 1
• 239000003102 growth factor Substances 0.000 description 1
• 239000001963 growth medium Substances 0.000 description 1
• 210000000777 hematopoietic system Anatomy 0.000 description 1
• BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
• 210000003630 histaminocyte Anatomy 0.000 description 1
• 239000003906 humectant Substances 0.000 description 1
• 150000003840 hydrochlorides Chemical class 0.000 description 1
• 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
• GRRNUXAQVGOGFE-NZSRVPFOSA-N hygromycin B Chemical compound O[C@@H]1[C@@H](NC)C[C@@H](N)[C@H](O)[C@H]1O[C@H]1[C@H]2O[C@@]3([C@@H]([C@@H](O)[C@@H](O)[C@@H](C(N)CO)O3)O)O[C@H]2[C@@H](O)[C@@H](CO)O1 GRRNUXAQVGOGFE-NZSRVPFOSA-N 0.000 description 1
• 229940097277 hygromycin b Drugs 0.000 description 1
• 230000008102 immune modulation Effects 0.000 description 1
• 102000027596 immune receptors Human genes 0.000 description 1
• 108091008915 immune receptors Proteins 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 230000005847 immunogenicity Effects 0.000 description 1
• 238000003364 immunohistochemistry Methods 0.000 description 1
• 229960003444 immunosuppressant agent Drugs 0.000 description 1
• 238000000338 in vitro Methods 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 239000007972 injectable composition Substances 0.000 description 1
• 210000005007 innate immune system Anatomy 0.000 description 1
• 229910052500 inorganic mineral Inorganic materials 0.000 description 1
• 238000003780 insertion Methods 0.000 description 1
• 230000037431 insertion Effects 0.000 description 1
• 230000010354 integration Effects 0.000 description 1
• 102000014909 interleukin-1 receptor activity proteins Human genes 0.000 description 1
• 108040006732 interleukin-1 receptor activity proteins Proteins 0.000 description 1
• 238000001361 intraarterial administration Methods 0.000 description 1
• 230000003834 intracellular effect Effects 0.000 description 1
• 230000031146 intracellular signal transduction Effects 0.000 description 1
• 238000000185 intracerebroventricular administration Methods 0.000 description 1
• 238000007917 intracranial administration Methods 0.000 description 1
• 238000007912 intraperitoneal administration Methods 0.000 description 1
• 238000007919 intrasynovial administration Methods 0.000 description 1
• 210000004153 islets of langerhan Anatomy 0.000 description 1
• QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
• 238000001738 isopycnic centrifugation Methods 0.000 description 1
• NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
• 210000001821 langerhans cell Anatomy 0.000 description 1
• 210000000265 leukocyte Anatomy 0.000 description 1
• 125000005647 linker group Chemical group 0.000 description 1
• 229920006008 lipopolysaccharide Polymers 0.000 description 1
• 239000006193 liquid solution Substances 0.000 description 1
• 239000006194 liquid suspension Substances 0.000 description 1
• 239000006166 lysate Substances 0.000 description 1
• 230000002934 lysing effect Effects 0.000 description 1
• 101710130522 mRNA export factor Proteins 0.000 description 1
• 229910001425 magnesium ion Inorganic materials 0.000 description 1
• 150000002690 malonic acid derivatives Chemical class 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 230000035800 maturation Effects 0.000 description 1
• 230000001404 mediated effect Effects 0.000 description 1
• 239000012528 membrane Substances 0.000 description 1
• 210000004779 membrane envelope Anatomy 0.000 description 1
• 239000004530 micro-emulsion Substances 0.000 description 1
• 244000005700 microbiome Species 0.000 description 1
• 239000008108 microcrystalline cellulose Substances 0.000 description 1
• 229940016286 microcrystalline cellulose Drugs 0.000 description 1
• 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
• 238000000520 microinjection Methods 0.000 description 1
• 239000011707 mineral Substances 0.000 description 1
• 235000010755 mineral Nutrition 0.000 description 1
• 239000002480 mineral oil Substances 0.000 description 1
• 235000010446 mineral oil Nutrition 0.000 description 1
• 238000010369 molecular cloning Methods 0.000 description 1
• CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
• 238000010172 mouse model Methods 0.000 description 1
• 208000036710 mucopolysaccharidosis type 3A Diseases 0.000 description 1
• 208000036707 mucopolysaccharidosis type 3C Diseases 0.000 description 1
• 208000012226 mucopolysaccharidosis type IIIA Diseases 0.000 description 1
• 208000012224 mucopolysaccharidosis type IIIC Diseases 0.000 description 1
• 210000003205 muscle Anatomy 0.000 description 1
• 238000001728 nano-filtration Methods 0.000 description 1
• 210000000653 nervous system Anatomy 0.000 description 1
• 210000000440 neutrophil Anatomy 0.000 description 1
• ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
• 238000002515 oligonucleotide synthesis Methods 0.000 description 1
• 239000004006 olive oil Substances 0.000 description 1
• 150000007524 organic acids Chemical class 0.000 description 1
• 235000005985 organic acids Nutrition 0.000 description 1
• 229960003104 ornithine Drugs 0.000 description 1
• 239000006179 pH buffering agent Substances 0.000 description 1
• 239000012188 paraffin wax Substances 0.000 description 1
• 230000001717 pathogenic effect Effects 0.000 description 1
• 239000000312 peanut oil Substances 0.000 description 1
• VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
• 239000002304 perfume Substances 0.000 description 1
• 210000005259 peripheral blood Anatomy 0.000 description 1
• 239000011886 peripheral blood Substances 0.000 description 1
• 239000003208 petroleum Substances 0.000 description 1
• 239000008177 pharmaceutical agent Substances 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
• CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 1
• 235000021317 phosphate Nutrition 0.000 description 1
• 108010079892 phosphoglycerol kinase Proteins 0.000 description 1
• PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
• 150000008298 phosphoramidates Chemical group 0.000 description 1
• 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 102000020233 phosphotransferase Human genes 0.000 description 1
• 239000004033 plastic Substances 0.000 description 1
• 229920003023 plastic Polymers 0.000 description 1
• 238000003752 polymerase chain reaction Methods 0.000 description 1
• 229920000136 polysorbate Polymers 0.000 description 1
• 239000011148 porous material Substances 0.000 description 1
• 230000004481 post-translational protein modification Effects 0.000 description 1
• 239000000843 powder Substances 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 229960004063 propylene glycol Drugs 0.000 description 1
• 230000001681 protective effect Effects 0.000 description 1
• 230000004850 protein–protein interaction Effects 0.000 description 1
• 230000017854 proteolysis Effects 0.000 description 1
• 229950010131 puromycin Drugs 0.000 description 1
• 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
• 230000006798 recombination Effects 0.000 description 1
• 238000005215 recombination Methods 0.000 description 1
• 230000014493 regulation of gene expression Effects 0.000 description 1
• 230000000241 respiratory effect Effects 0.000 description 1
• 239000003340 retarding agent Substances 0.000 description 1
• 210000001525 retina Anatomy 0.000 description 1
• 108010054126 retinoid isomerohydrolase Proteins 0.000 description 1
• 230000007441 retrograde transport Effects 0.000 description 1
• 230000001177 retroviral effect Effects 0.000 description 1
• 101150098213 rev gene Proteins 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 125000002652 ribonucleotide group Chemical group 0.000 description 1
• 230000007017 scission Effects 0.000 description 1
• 239000008159 sesame oil Substances 0.000 description 1
• 235000011803 sesame oil Nutrition 0.000 description 1
• 230000009450 sialylation Effects 0.000 description 1
• 208000007056 sickle cell anemia Diseases 0.000 description 1
• 150000004760 silicates Chemical class 0.000 description 1
• RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
• 235000012239 silicon dioxide Nutrition 0.000 description 1
• 238000005475 siliconizing Methods 0.000 description 1
• 238000002741 site-directed mutagenesis Methods 0.000 description 1
• 210000002460 smooth muscle Anatomy 0.000 description 1
• 229910000029 sodium carbonate Inorganic materials 0.000 description 1
• 239000001509 sodium citrate Substances 0.000 description 1
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
• 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
• 239000002047 solid lipid nanoparticle Substances 0.000 description 1
• 238000000527 sonication Methods 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 239000003549 soybean oil Substances 0.000 description 1
• 235000012424 soybean oil Nutrition 0.000 description 1
• 208000002320 spinal muscular atrophy Diseases 0.000 description 1
• 239000007921 spray Substances 0.000 description 1
• 239000008223 sterile water Substances 0.000 description 1
• 239000003206 sterilizing agent Substances 0.000 description 1
• 238000003756 stirring Methods 0.000 description 1
• 239000000758 substrate Substances 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 108060007951 sulfatase Proteins 0.000 description 1
• 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
• 239000003765 sweetening agent Substances 0.000 description 1
• 210000000225 synapse Anatomy 0.000 description 1
• 210000002437 synoviocyte Anatomy 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 239000000454 talc Substances 0.000 description 1
• 229910052623 talc Inorganic materials 0.000 description 1
• 235000012222 talc Nutrition 0.000 description 1
• 108700004027 tat Genes Proteins 0.000 description 1
• 101150098170 tat gene Proteins 0.000 description 1
• 102000013498 tau Proteins Human genes 0.000 description 1
• 108010026424 tau Proteins Proteins 0.000 description 1
• 229930101283 tetracycline Natural products 0.000 description 1
• 229960002180 tetracycline Drugs 0.000 description 1
• 235000019364 tetracycline Nutrition 0.000 description 1
• 150000003522 tetracyclines Chemical class 0.000 description 1
• BSYVTEYKTMYBMK-UHFFFAOYSA-N tetrahydrofurfuryl alcohol Chemical compound OCC1CCCO1 BSYVTEYKTMYBMK-UHFFFAOYSA-N 0.000 description 1
• 229940124597 therapeutic agent Drugs 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 230000005026 transcription initiation Effects 0.000 description 1
• 230000005030 transcription termination Effects 0.000 description 1
• 230000002103 transcriptional effect Effects 0.000 description 1
• 238000003151 transfection method Methods 0.000 description 1
• 238000003146 transient transfection Methods 0.000 description 1
• 230000000472 traumatic effect Effects 0.000 description 1
• 230000001960 triggered effect Effects 0.000 description 1
• 239000013638 trimer Substances 0.000 description 1
• 230000010415 tropism Effects 0.000 description 1
• 210000004881 tumor cell Anatomy 0.000 description 1
• 230000034512 ubiquitination Effects 0.000 description 1
• 238000010798 ubiquitination Methods 0.000 description 1
• 241000712461 unidentified influenza virus Species 0.000 description 1
• 230000003827 upregulation Effects 0.000 description 1
• 208000007089 vaccinia Diseases 0.000 description 1
• 235000013311 vegetables Nutrition 0.000 description 1
• 230000029812 viral genome replication Effects 0.000 description 1